

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.91300741 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.52731453 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.49830138 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.49830138 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.29722839 |
| 6 | cytidine deamination (GO:0009972) | 5.17011690 |
| 7 | cytidine metabolic process (GO:0046087) | 5.17011690 |
| 8 | cytidine catabolic process (GO:0006216) | 5.17011690 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.08159535 |
| 10 | leukocyte aggregation (GO:0070486) | 4.86668763 |
| 11 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.73025770 |
| 12 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.72686635 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.66110415 |
| 14 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.65276728 |
| 15 | DNA deamination (GO:0045006) | 4.59249983 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.57094461 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.44859120 |
| 18 | T cell migration (GO:0072678) | 4.36562399 |
| 19 | positive regulation of antigen processing and presentation (GO:0002579) | 4.28891862 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.28225596 |
| 21 | actin nucleation (GO:0045010) | 4.22969762 |
| 22 | negative T cell selection (GO:0043383) | 4.21283598 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.20843795 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.18497529 |
| 25 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.10590130 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.10590130 |
| 27 | positive regulation of interferon-alpha production (GO:0032727) | 4.05796889 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.98546967 |
| 29 | cellular response to type I interferon (GO:0071357) | 3.98546967 |
| 30 | cellular response to zinc ion (GO:0071294) | 3.98427993 |
| 31 | sequestering of actin monomers (GO:0042989) | 3.98419771 |
| 32 | response to type I interferon (GO:0034340) | 3.97360361 |
| 33 | positive thymic T cell selection (GO:0045059) | 3.96706014 |
| 34 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.89360832 |
| 35 | regulation of interferon-alpha production (GO:0032647) | 3.85914523 |
| 36 | T cell receptor signaling pathway (GO:0050852) | 3.85465333 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.85112162 |
| 38 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.81928142 |
| 39 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.78268728 |
| 40 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.78129858 |
| 41 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.77342769 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.75983354 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75924822 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.75924822 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75924822 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75924822 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75924822 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.75924822 |
| 49 | regulation of regulatory T cell differentiation (GO:0045589) | 3.73773406 |
| 50 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.72203190 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.70825474 |
| 52 | cellular response to interferon-beta (GO:0035458) | 3.70750254 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69399311 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.69399311 |
| 55 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.67220756 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65497119 |
| 57 | response to peptidoglycan (GO:0032494) | 3.64193273 |
| 58 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.62630948 |
| 59 | granulocyte activation (GO:0036230) | 3.62563571 |
| 60 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59743793 |
| 61 | neutrophil activation (GO:0042119) | 3.59340004 |
| 62 | B cell mediated immunity (GO:0019724) | 3.58733782 |
| 63 | defense response to protozoan (GO:0042832) | 3.54802445 |
| 64 | negative regulation of T cell apoptotic process (GO:0070233) | 3.54030055 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 3.52669083 |
| 66 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.51256135 |
| 67 | positive regulation of cell killing (GO:0031343) | 3.50701325 |
| 68 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.50456676 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.49992283 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.48692660 |
| 71 | regulation of cell killing (GO:0031341) | 3.47089412 |
| 72 | * respiratory burst (GO:0045730) | 3.46346278 |
| 73 | B cell receptor signaling pathway (GO:0050853) | 3.45559469 |
| 74 | interferon-gamma production (GO:0032609) | 3.45528160 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 3.43798416 |
| 76 | thymic T cell selection (GO:0045061) | 3.42940714 |
| 77 | mast cell activation (GO:0045576) | 3.37141389 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33204410 |
| 79 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.31124071 |
| 80 | cellular response to interleukin-15 (GO:0071350) | 3.29987067 |
| 81 | natural killer cell mediated immunity (GO:0002228) | 3.29909768 |
| 82 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.29909768 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.28793467 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 3.27382073 |
| 85 | regulation of activation of Janus kinase activity (GO:0010533) | 3.25664804 |
| 86 | T cell costimulation (GO:0031295) | 3.24404554 |
| 87 | lymphocyte migration (GO:0072676) | 3.23832335 |
| 88 | response to interleukin-15 (GO:0070672) | 3.21696956 |
| 89 | lymphocyte costimulation (GO:0031294) | 3.20621138 |
| 90 | response to protozoan (GO:0001562) | 3.19853448 |
| 91 | positive regulation of B cell mediated immunity (GO:0002714) | 3.19295829 |
| 92 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.19295829 |
| 93 | T cell selection (GO:0045058) | 3.18385172 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17207641 |
| 95 | natural killer cell activation (GO:0030101) | 3.16466096 |
| 96 | positive regulation of interleukin-2 production (GO:0032743) | 3.16279717 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 3.16134375 |
| 98 | myeloid cell activation involved in immune response (GO:0002275) | 3.15411536 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15063186 |
| 100 | response to interferon-beta (GO:0035456) | 3.13946084 |
| 101 | regulation of T cell tolerance induction (GO:0002664) | 3.13341289 |
| 102 | positive T cell selection (GO:0043368) | 3.12884158 |
| 103 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.12123923 |
| 104 | leukocyte cell-cell adhesion (GO:0007159) | 3.10260505 |
| 105 | activated T cell proliferation (GO:0050798) | 3.10065679 |
| 106 | positive regulation of isotype switching (GO:0045830) | 3.09141956 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 3.09127600 |
| 108 | negative regulation of viral genome replication (GO:0045071) | 3.08547259 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.07327335 |
| 110 | positive regulation of interleukin-4 production (GO:0032753) | 3.07078454 |
| 111 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06268978 |
| 112 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05860803 |
| 113 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.04393626 |
| 114 | cellular extravasation (GO:0045123) | 3.03962277 |
| 115 | dendritic cell chemotaxis (GO:0002407) | 3.02629199 |
| 116 | lymphocyte chemotaxis (GO:0048247) | 3.02483793 |
| 117 | detection of bacterium (GO:0016045) | 3.00253489 |
| 118 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.99757522 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.99074124 |
| 120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.98640538 |
| 121 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.98178597 |
| 122 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97204320 |
| 123 | positive regulation of interleukin-12 production (GO:0032735) | 2.96301326 |
| 124 | cellular defense response (GO:0006968) | 2.95471549 |
| 125 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.94708690 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.94346472 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.93044955 |
| 128 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92777874 |
| 129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.92715378 |
| 130 | positive regulation of interferon-beta production (GO:0032728) | 2.91675565 |
| 131 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.91655010 |
| 132 | superoxide anion generation (GO:0042554) | 2.90501657 |
| 133 | NIK/NF-kappaB signaling (GO:0038061) | 2.90244286 |
| 134 | detection of other organism (GO:0098543) | 2.90101775 |
| 135 | tolerance induction (GO:0002507) | 2.90095315 |
| 136 | positive regulation of T cell mediated immunity (GO:0002711) | 2.90036865 |
| 137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89922280 |
| 138 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88759125 |
| 139 | positive regulation of defense response to virus by host (GO:0002230) | 2.88592434 |
| 140 | positive regulation of interferon-gamma production (GO:0032729) | 2.88400913 |
| 141 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86961837 |
| 142 | leukocyte degranulation (GO:0043299) | 2.86688882 |
| 143 | positive regulation of B cell differentiation (GO:0045579) | 2.86063322 |
| 144 | Peyers patch development (GO:0048541) | 2.86023502 |
| 145 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.86023502 |
| 146 | cellular response to interferon-gamma (GO:0071346) | 2.84289999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.14445760 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.33157483 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.52729959 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.93843646 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.91710293 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.31656543 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.23300618 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67264288 |
| 9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.44378591 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44244728 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27615733 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.27506124 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.24075043 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09352937 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55903466 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.55235455 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45304379 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40795615 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.40120431 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.32100816 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31532704 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25957002 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.22755303 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19196022 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.06130725 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02725011 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00389356 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99748712 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89455392 |
| 30 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87559903 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82237298 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77576151 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72613417 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.70291867 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68255426 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68184225 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65135100 |
| 38 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64663229 |
| 39 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61794781 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61256015 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60874357 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59320819 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58434738 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.57767232 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56828949 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54220625 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53641057 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48013395 |
| 49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46152987 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41998564 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37115693 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36453797 |
| 53 | * MAF_26560356_Chip-Seq_TH2_Human | 1.35816336 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34768289 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31492073 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29930660 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28390720 |
| 58 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.27797328 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25029483 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24045360 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21924939 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20278855 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19514192 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18404036 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16225398 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15491631 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14122909 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13567455 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13424599 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13219383 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12020758 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11630682 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09099733 |
| 74 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07363114 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07195179 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04961528 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04330550 |
| 78 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04185582 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00669843 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00384606 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97752384 |
| 82 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96610770 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95124746 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94502508 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93724837 |
| 86 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93094138 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91904630 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90057735 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89686456 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89620782 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88052766 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87857675 |
| 93 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.85482197 |
| 94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82374520 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81132931 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81006300 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80387405 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78118301 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77373335 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75829042 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74659406 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.74615699 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72657982 |
| 104 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72627280 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.72504938 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72022918 |
| 107 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.70815911 |
| 108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68802037 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67884197 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67486181 |
| 111 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.65382724 |
| 112 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64942790 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63692963 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.62909651 |
| 115 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.62813238 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61532025 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.60668675 |
| 118 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59431479 |
| 119 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.58779431 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57983567 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.56948083 |
| 122 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.56169665 |
| 123 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55831605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.46435199 |
| 2 | MP0005671_abnormal_response_to | 4.11348927 |
| 3 | MP0009785_altered_susceptibility_to | 3.87821652 |
| 4 | MP0003436_decreased_susceptibility_to | 3.57958083 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.49160639 |
| 6 | MP0000685_abnormal_immune_system | 3.48170823 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.45363631 |
| 8 | MP0006082_CNS_inflammation | 3.42763190 |
| 9 | MP0001790_abnormal_immune_system | 3.29703815 |
| 10 | MP0005387_immune_system_phenotype | 3.29703815 |
| 11 | MP0001800_abnormal_humoral_immune | 3.21557815 |
| 12 | MP0005025_abnormal_response_to | 3.19975730 |
| 13 | MP0002452_abnormal_antigen_presenting | 3.03100899 |
| 14 | MP0003303_peritoneal_inflammation | 2.94943763 |
| 15 | MP0002419_abnormal_innate_immunity | 2.94072931 |
| 16 | MP0002723_abnormal_immune_serum | 2.93925153 |
| 17 | MP0001819_abnormal_immune_cell | 2.78894755 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.77848344 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.67072120 |
| 20 | MP0003724_increased_susceptibility_to | 2.62418227 |
| 21 | MP0002006_tumorigenesis | 2.47196517 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.42430110 |
| 23 | MP0002405_respiratory_system_inflammati | 2.26184926 |
| 24 | MP0004510_myositis | 2.22497922 |
| 25 | MP0002398_abnormal_bone_marrow | 2.19647131 |
| 26 | MP0000716_abnormal_immune_system | 2.14860938 |
| 27 | MP0001853_heart_inflammation | 2.09736437 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.07423573 |
| 29 | MP0001845_abnormal_inflammatory_respons | 2.00031487 |
| 30 | MP0004947_skin_inflammation | 1.96792760 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.96540887 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.91816337 |
| 33 | MP0005310_abnormal_salivary_gland | 1.86741559 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.82735182 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.74366009 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.74279342 |
| 37 | MP0002429_abnormal_blood_cell | 1.71539097 |
| 38 | MP0002722_abnormal_immune_system | 1.68315016 |
| 39 | MP0003448_altered_tumor_morphology | 1.65094448 |
| 40 | MP0009764_decreased_sensitivity_to | 1.60526522 |
| 41 | MP0000858_altered_metastatic_potential | 1.59690830 |
| 42 | MP0008469_abnormal_protein_level | 1.59316972 |
| 43 | MP0002933_joint_inflammation | 1.43993788 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.40999319 |
| 45 | MP0001873_stomach_inflammation | 1.34110344 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.33358600 |
| 47 | MP0003866_abnormal_defecation | 1.32446872 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.24404010 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.23631554 |
| 50 | MP0000343_altered_response_to | 1.21009905 |
| 51 | MP0005166_decreased_susceptibility_to | 1.14490235 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.03317596 |
| 53 | MP0003075_altered_response_to | 1.00416827 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 0.99910016 |
| 55 | MP0009763_increased_sensitivity_to | 0.98131594 |
| 56 | MP0003172_abnormal_lysosome_physiology | 0.97410181 |
| 57 | MP0001545_abnormal_hematopoietic_system | 0.95319113 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 0.95319113 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 0.92643341 |
| 60 | MP0001851_eye_inflammation | 0.91015652 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 0.85303854 |
| 62 | MP0002396_abnormal_hematopoietic_system | 0.84724287 |
| 63 | MP0003186_abnormal_redox_activity | 0.81329318 |
| 64 | MP0003183_abnormal_peptide_metabolism | 0.81047721 |
| 65 | MP0003045_fibrosis | 0.80291815 |
| 66 | MP0000490_abnormal_crypts_of | 0.78250920 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 0.76592407 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 0.75256309 |
| 69 | MP0002019_abnormal_tumor_incidence | 0.74813915 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.73762695 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.71819565 |
| 72 | MP0005390_skeleton_phenotype | 0.70227656 |
| 73 | MP0003646_muscle_fatigue | 0.70050028 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.69782820 |
| 75 | MP0004883_abnormal_blood_vessel | 0.68361620 |
| 76 | MP0009278_abnormal_bone_marrow | 0.68096811 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.67806249 |
| 78 | MP0000604_amyloidosis | 0.66184282 |
| 79 | MP0003828_pulmonary_edema | 0.65126790 |
| 80 | MP0001663_abnormal_digestive_system | 0.62670412 |
| 81 | MP0003795_abnormal_bone_structure | 0.62452748 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.62106251 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.60916209 |
| 84 | MP0000249_abnormal_blood_vessel | 0.60032328 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.59625921 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.58604590 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.55897892 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.55781649 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.55320916 |
| 90 | MP0005164_abnormal_response_to | 0.54083261 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.53560255 |
| 92 | MP0008872_abnormal_physiological_respon | 0.52673367 |
| 93 | MP0009840_abnormal_foam_cell | 0.52239181 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.52004306 |
| 95 | MP0003878_abnormal_ear_physiology | 0.52004306 |
| 96 | MP0001919_abnormal_reproductive_system | 0.51982339 |
| 97 | MP0002132_abnormal_respiratory_system | 0.51582055 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.50125220 |
| 99 | MP0010307_abnormal_tumor_latency | 0.49594893 |
| 100 | MP0003786_premature_aging | 0.49243708 |
| 101 | MP0000371_diluted_coat_color | 0.49136726 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.48337818 |
| 103 | MP0002254_reproductive_system_inflammat | 0.48316036 |
| 104 | MP0003252_abnormal_bile_duct | 0.47904936 |
| 105 | MP0002009_preneoplasia | 0.47686121 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.47391601 |
| 107 | MP0003690_abnormal_glial_cell | 0.44962735 |
| 108 | MP0001191_abnormal_skin_condition | 0.44660042 |
| 109 | MP0005023_abnormal_wound_healing | 0.44154551 |
| 110 | MP0008873_increased_physiological_sensi | 0.43614176 |
| 111 | MP0008874_decreased_physiological_sensi | 0.43375916 |
| 112 | MP0001881_abnormal_mammary_gland | 0.42755719 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.42715734 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.42598015 |
| 115 | MP0000920_abnormal_myelination | 0.42050991 |
| 116 | MP0008260_abnormal_autophagy | 0.41983935 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.41671532 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.41425230 |
| 119 | MP0000609_abnormal_liver_physiology | 0.41387645 |
| 120 | MP0005451_abnormal_body_composition | 0.41352382 |
| 121 | MP0004381_abnormal_hair_follicle | 0.39256503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.12595512 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.66091706 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.90616833 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.86815667 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.37784498 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.71841126 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.61752920 |
| 8 | Stomatitis (HP:0010280) | 4.51504640 |
| 9 | Increased IgM level (HP:0003496) | 4.43499364 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.41709843 |
| 11 | Recurrent skin infections (HP:0001581) | 4.35616483 |
| 12 | Myositis (HP:0100614) | 4.35415320 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.32441016 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 4.32441016 |
| 15 | Recurrent bronchitis (HP:0002837) | 4.16253345 |
| 16 | Abnormality of T cell number (HP:0011839) | 4.14513981 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09733055 |
| 18 | Obstructive lung disease (HP:0006536) | 4.09733055 |
| 19 | Recurrent viral infections (HP:0004429) | 4.06592493 |
| 20 | T lymphocytopenia (HP:0005403) | 3.97791310 |
| 21 | Vasculitis (HP:0002633) | 3.91792189 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.88615909 |
| 23 | Gingivitis (HP:0000230) | 3.84445328 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.83010014 |
| 25 | Aplastic anemia (HP:0001915) | 3.82275297 |
| 26 | Agammaglobulinemia (HP:0004432) | 3.66579845 |
| 27 | Meningitis (HP:0001287) | 3.65938244 |
| 28 | Optic neuritis (HP:0100653) | 3.52673110 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.52673110 |
| 30 | Orchitis (HP:0100796) | 3.50002637 |
| 31 | Cellulitis (HP:0100658) | 3.49135517 |
| 32 | Chronic otitis media (HP:0000389) | 3.48087766 |
| 33 | IgM deficiency (HP:0002850) | 3.47466997 |
| 34 | Abnormality of T cells (HP:0002843) | 3.46983372 |
| 35 | IgG deficiency (HP:0004315) | 3.39144416 |
| 36 | Pustule (HP:0200039) | 3.26888810 |
| 37 | Lymphopenia (HP:0001888) | 3.26661627 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.22085070 |
| 39 | Combined immunodeficiency (HP:0005387) | 3.19822464 |
| 40 | Severe combined immunodeficiency (HP:0004430) | 3.14772214 |
| 41 | Recurrent sinusitis (HP:0011108) | 3.13627022 |
| 42 | Recurrent pneumonia (HP:0006532) | 3.12076886 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 3.11200207 |
| 44 | Gastrointestinal stroma tumor (HP:0100723) | 3.10270784 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 3.05081480 |
| 46 | Basal ganglia calcification (HP:0002135) | 3.01009326 |
| 47 | Hypoproteinemia (HP:0003075) | 2.99428802 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.93881974 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.92648122 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.88000687 |
| 51 | Hemoptysis (HP:0002105) | 2.86649493 |
| 52 | Leukocytosis (HP:0001974) | 2.86025038 |
| 53 | Nasal polyposis (HP:0100582) | 2.85297897 |
| 54 | Recurrent lower respiratory tract infections (HP:0002783) | 2.80969679 |
| 55 | Thyroiditis (HP:0100646) | 2.78211271 |
| 56 | IgA deficiency (HP:0002720) | 2.76848268 |
| 57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73112984 |
| 58 | Urticaria (HP:0001025) | 2.72531658 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 2.67377672 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.65370232 |
| 61 | Chronic diarrhea (HP:0002028) | 2.61186605 |
| 62 | Periodontitis (HP:0000704) | 2.60298187 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.59324882 |
| 64 | Osteomyelitis (HP:0002754) | 2.58801258 |
| 65 | Chest pain (HP:0100749) | 2.57945818 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.57299082 |
| 67 | Colitis (HP:0002583) | 2.56362228 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.53383120 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52213271 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.49554420 |
| 71 | Eosinophilia (HP:0001880) | 2.47242127 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.45178538 |
| 73 | Joint swelling (HP:0001386) | 2.43384470 |
| 74 | Emphysema (HP:0002097) | 2.42784859 |
| 75 | Increased IgE level (HP:0003212) | 2.40674268 |
| 76 | Cheilitis (HP:0100825) | 2.38118725 |
| 77 | Petechiae (HP:0000967) | 2.36405727 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.36229058 |
| 79 | Verrucae (HP:0200043) | 2.34664883 |
| 80 | Papilloma (HP:0012740) | 2.34664883 |
| 81 | B lymphocytopenia (HP:0010976) | 2.34627802 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.34627802 |
| 83 | Prostate neoplasm (HP:0100787) | 2.33565479 |
| 84 | Arterial thrombosis (HP:0004420) | 2.33215904 |
| 85 | Sepsis (HP:0100806) | 2.31873637 |
| 86 | Gangrene (HP:0100758) | 2.30004841 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.28200224 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27591282 |
| 89 | Encephalitis (HP:0002383) | 2.27287410 |
| 90 | Bronchitis (HP:0012387) | 2.26281885 |
| 91 | Thrombocytosis (HP:0001894) | 2.23392816 |
| 92 | Chronic sinusitis (HP:0011109) | 2.22206644 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.20960798 |
| 94 | Skin ulcer (HP:0200042) | 2.20274246 |
| 95 | Pulmonary embolism (HP:0002204) | 2.20177142 |
| 96 | Acute hepatic failure (HP:0006554) | 2.19397063 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.18900211 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.18249250 |
| 99 | Granulocytopenia (HP:0001913) | 2.17715828 |
| 100 | Gingival bleeding (HP:0000225) | 2.17692987 |
| 101 | Pulmonary fibrosis (HP:0002206) | 2.17529965 |
| 102 | Hypoplasia of the thymus (HP:0000778) | 2.13198377 |
| 103 | Recurrent otitis media (HP:0000403) | 2.12924044 |
| 104 | Epistaxis (HP:0000421) | 2.10690887 |
| 105 | Arthralgia (HP:0002829) | 2.10382937 |
| 106 | Restrictive lung disease (HP:0002091) | 2.08589619 |
| 107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08575891 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08575891 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08575891 |
| 110 | Disinhibition (HP:0000734) | 2.06410197 |
| 111 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.05414216 |
| 112 | Dysostosis multiplex (HP:0000943) | 2.04023076 |
| 113 | Lymphoma (HP:0002665) | 2.03008667 |
| 114 | Abnormality of the prostate (HP:0008775) | 2.01976478 |
| 115 | Poor head control (HP:0002421) | 2.01277269 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 1.99134312 |
| 117 | Skin rash (HP:0000988) | 1.95331998 |
| 118 | Prolonged bleeding time (HP:0003010) | 1.93303055 |
| 119 | Purpura (HP:0000979) | 1.92041175 |
| 120 | Anorexia (HP:0002039) | 1.91885084 |
| 121 | Pancytopenia (HP:0001876) | 1.84316695 |
| 122 | Polyneuropathy (HP:0001271) | 1.84151605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.40976305 |
| 2 | BLK | 3.84117311 |
| 3 | TXK | 3.77418837 |
| 4 | MAP3K14 | 3.69554605 |
| 5 | TBK1 | 3.16887089 |
| 6 | TYK2 | 3.14060271 |
| 7 | RIPK4 | 3.07448397 |
| 8 | IKBKE | 2.90688479 |
| 9 | JAK3 | 2.87022402 |
| 10 | IRAK4 | 2.85271391 |
| 11 | PBK | 2.38901779 |
| 12 | ZAP70 | 2.35437047 |
| 13 | JAK1 | 2.15135173 |
| 14 | NME2 | 2.11436121 |
| 15 | KIT | 2.07777593 |
| 16 | SYK | 1.99679745 |
| 17 | IRAK3 | 1.98736527 |
| 18 | IKBKB | 1.98662877 |
| 19 | ERN1 | 1.93261012 |
| 20 | CSK | 1.85306655 |
| 21 | BCKDK | 1.79889587 |
| 22 | BTK | 1.77634767 |
| 23 | MST4 | 1.76963532 |
| 24 | FGFR4 | 1.72385049 |
| 25 | ITK | 1.70400996 |
| 26 | TEC | 1.64528141 |
| 27 | LCK | 1.62595368 |
| 28 | TESK2 | 1.48237227 |
| 29 | CSF1R | 1.45945885 |
| 30 | HCK | 1.45760848 |
| 31 | LYN | 1.44928978 |
| 32 | KDR | 1.42189857 |
| 33 | PIM2 | 1.40991970 |
| 34 | STK10 | 1.40262399 |
| 35 | MAP3K13 | 1.38834077 |
| 36 | MAP3K12 | 1.35972692 |
| 37 | TAOK3 | 1.34808725 |
| 38 | FGFR3 | 1.32170135 |
| 39 | SCYL2 | 1.29709164 |
| 40 | GRK6 | 1.29497253 |
| 41 | NEK9 | 1.20049827 |
| 42 | PIM1 | 1.11608581 |
| 43 | CHUK | 1.05367087 |
| 44 | NLK | 1.02996152 |
| 45 | TESK1 | 1.00768599 |
| 46 | RPS6KA4 | 1.00403142 |
| 47 | JAK2 | 0.98939746 |
| 48 | CLK1 | 0.94029822 |
| 49 | LRRK2 | 0.93690303 |
| 50 | SIK3 | 0.92295601 |
| 51 | PRKCQ | 0.90811354 |
| 52 | MARK3 | 0.88514456 |
| 53 | CAMKK2 | 0.88239823 |
| 54 | LIMK1 | 0.85834815 |
| 55 | STK4 | 0.84956357 |
| 56 | VRK2 | 0.84879190 |
| 57 | MYLK | 0.79539604 |
| 58 | FES | 0.72501308 |
| 59 | PASK | 0.71702915 |
| 60 | FGR | 0.69757733 |
| 61 | ZAK | 0.68252243 |
| 62 | BMPR2 | 0.67369825 |
| 63 | CAMKK1 | 0.65656597 |
| 64 | MAPKAPK3 | 0.63752210 |
| 65 | PRPF4B | 0.61316935 |
| 66 | PRKCH | 0.61221809 |
| 67 | PRKCD | 0.61159250 |
| 68 | MATK | 0.61018086 |
| 69 | SIK2 | 0.59497723 |
| 70 | EPHB1 | 0.58487271 |
| 71 | ABL1 | 0.57998167 |
| 72 | DAPK1 | 0.56574933 |
| 73 | TNK2 | 0.56486975 |
| 74 | ABL2 | 0.55728282 |
| 75 | TGFBR2 | 0.53248651 |
| 76 | VRK1 | 0.52949045 |
| 77 | MAP3K10 | 0.52716783 |
| 78 | FYN | 0.50601645 |
| 79 | EIF2AK1 | 0.50052106 |
| 80 | EIF2AK3 | 0.49222853 |
| 81 | TRPM7 | 0.48446309 |
| 82 | BMX | 0.47654399 |
| 83 | MUSK | 0.47027173 |
| 84 | IRAK1 | 0.46844204 |
| 85 | EIF2AK2 | 0.44146893 |
| 86 | TAOK2 | 0.44117128 |
| 87 | GRK7 | 0.43443771 |
| 88 | EGFR | 0.41314450 |
| 89 | GRK1 | 0.41208880 |
| 90 | IRAK2 | 0.40517988 |
| 91 | MAP2K2 | 0.40336614 |
| 92 | ADRBK2 | 0.39766657 |
| 93 | MAPK12 | 0.38510653 |
| 94 | INSR | 0.38087026 |
| 95 | MAP2K3 | 0.37317978 |
| 96 | PDK1 | 0.36930574 |
| 97 | EPHA3 | 0.36631379 |
| 98 | MAP3K3 | 0.35626493 |
| 99 | MAP3K5 | 0.32073355 |
| 100 | DAPK3 | 0.31804786 |
| 101 | RPS6KA5 | 0.31617108 |
| 102 | ACVR1B | 0.30253305 |
| 103 | YES1 | 0.29096316 |
| 104 | CDK19 | 0.27577514 |
| 105 | IGF1R | 0.26744060 |
| 106 | TTN | 0.26409402 |
| 107 | MAPKAPK2 | 0.26225000 |
| 108 | STK16 | 0.25556821 |
| 109 | MAP4K2 | 0.24531297 |
| 110 | MAPK3 | 0.23791599 |
| 111 | NUAK1 | 0.22904016 |
| 112 | TLK1 | 0.22820342 |
| 113 | MAP3K11 | 0.22029855 |
| 114 | HIPK2 | 0.21672778 |
| 115 | PRKCA | 0.20383052 |
| 116 | PIK3CG | 0.18201925 |
| 117 | ADRBK1 | 0.17761177 |
| 118 | MAP3K1 | 0.17512063 |
| 119 | MAP2K6 | 0.16825359 |
| 120 | MAPK7 | 0.16794130 |
| 121 | DMPK | 0.16721690 |
| 122 | RPS6KA6 | 0.16467841 |
| 123 | SRC | 0.15919796 |
| 124 | PDGFRB | 0.14035384 |
| 125 | MAPK11 | 0.13152153 |
| 126 | MST1R | 0.11780173 |
| 127 | CDK4 | 0.11694848 |
| 128 | ARAF | 0.11616364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.83285550 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.76755625 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.15468474 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.10653763 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.93032469 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.76955409 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.66565863 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.50099364 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.48418851 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43732603 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30219803 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29075777 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.25673330 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18947190 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17077774 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.11934793 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.06497154 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04680133 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99298178 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92310424 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91039772 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.89592505 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.86073985 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.79614588 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.78061162 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76290308 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69795935 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66999110 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61728751 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.57628058 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.53753536 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50135849 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49782674 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49018912 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47066176 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42969574 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41112402 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39744025 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.37352248 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.35991641 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33482891 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.22388586 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16198173 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15428902 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.12803386 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10006019 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.09148865 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 0.90440502 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85038137 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.84800801 |
| 51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83264723 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75671479 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72858258 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72121944 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68879877 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67433584 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.67043579 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64387978 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62594722 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62573433 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57880804 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50095886 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48823660 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47415884 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43605950 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41327093 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.39793537 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.38775971 |
| 69 | Ribosome_Homo sapiens_hsa03010 | 0.37982231 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37677182 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37623381 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36867529 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34840621 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.33530269 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33511076 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33334800 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33198260 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33017559 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32763635 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32397110 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32003233 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.29041916 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28560404 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28064823 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27458976 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26776617 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26369519 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25704781 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24288097 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.23457488 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.21684565 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21123980 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21104846 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20587419 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17452420 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.16749669 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16738502 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16118050 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.15546123 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12418757 |
| 101 | DNA replication_Homo sapiens_hsa03030 | 0.12026300 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11490446 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.11485729 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10454425 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.08674305 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.07574575 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.07283145 |
| 108 | Homologous recombination_Homo sapiens_hsa03440 | 0.06313313 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.06262196 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.06249589 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06230163 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05844172 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.05762706 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.05741700 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05679276 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.04989768 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.04675357 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.04198735 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.00435035 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0140226 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0138040 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0121349 |

